Back to search

Article

Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET3 mice and attenuates Alzheimer’s-like pathology

2025-06-15

Abstract excerpt

Aging is the strongest risk factor for cognitive decline and Alzheimer’s disease (AD), yet the mechanisms underlying brain aging and their modulation by pharmacological interventions remain poorly defined. The hippocampus, essential for learning and memory, is particularly vulnerable to metabolic stress and inflammation. Canagliflozin (Cana), an FDA-approved sodium-glucose co-transporter 2 inhibitor (SGLT2i) for t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cd8a4988-f30f-581b-b644-ab39f85ce19c
DOI
10.1101/2025.06.10.658747
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET3 mice and attenuates Alzheimer’s-like pathologyDOI 10.1101/2025.06.10.658747
Select a neighboring publication to make it the new centre.